Literature DB >> 26880657

The impact of obstructive sleep apnea on nonalcoholic fatty liver disease in patients with severe obesity.

Peter Benotti1, G Craig Wood1, George Argyropoulos1, Allan Pack2, Brendan T Keenan2, Xiang Gao3, Glenn Gerhard4, Christopher Still1.   

Abstract

OBJECTIVE: Obstructive sleep apnea (OSA) is common among candidates for bariatric surgery. OSA and its associated intermittent hypoxia have been implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis. A large cohort of bariatric surgery patients was studied in an effort to explore the relationship between OSA severity, hypoxia, metabolic syndrome, and the severity of NAFLD.
METHODS: Bariatric surgery candidates who underwent both polysomnography and liver biopsy were studied. The severity of OSA as determined by the apnea-hypopnea index (AHI) and parameters of hypoxia was studied in relation to extent of abnormalities of liver histology as measured by the presence of hepatic steatosis, inflammation, and fibrosis.
RESULTS: The study cohort included 362 patients with a mean age of 46.2 years and BMI of 49.9 kg/m(2) . On the basis of AHI, 26% of the cohort had no OSA, 32% mild OSA, 22% moderate OSA, and 20% severe OSA. For the study subjects without metabolic syndrome, positive correlations were found between OSA severity, as measured by AHI, and parameters of hypoxia, with the severity of NAFLD.
CONCLUSIONS: OSA severity and its accompanying hypoxia are associated with the severity of NAFLD.
© 2016 The Obesity Society.

Entities:  

Mesh:

Year:  2016        PMID: 26880657      PMCID: PMC4936917          DOI: 10.1002/oby.21409

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  32 in total

1.  Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader; Gianfranco Pagano
Journal:  Ann Med       Date:  2010-11-02       Impact factor: 4.709

2.  Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

Authors:  Zobair M Younossi; Maria Stepanova; Mariam Afendy; Yun Fang; Youssef Younossi; Hesham Mir; Manirath Srishord
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-25       Impact factor: 11.382

3.  Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology.

Authors:  Kathleen E Corey; Joseph Misdraji; Lou Gelrud; Lindsay Y King; Hui Zheng; Atul Malhotra; Raymond T Chung
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

4.  Oxygen desaturation index from nocturnal oximetry: a sensitive and specific tool to detect sleep-disordered breathing in surgical patients.

Authors:  Frances Chung; Pu Liao; Hisham Elsaid; Sazzadul Islam; Colin M Shapiro; Yuming Sun
Journal:  Anesth Analg       Date:  2012-02-24       Impact factor: 5.108

Review 5.  Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2006-05       Impact factor: 4.359

6.  Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia.

Authors:  Cansel Türkay; Duygu Ozol; Benan Kasapoğlu; Ismail Kirbas; Zeki Yıldırım; Ramazan Yiğitoğlu
Journal:  Respir Care       Date:  2011-07-12       Impact factor: 2.258

7.  Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease.

Authors:  Shikha S Sundaram; Ronald J Sokol; Kelley E Capocelli; Zhaoxing Pan; Jillian S Sullivan; Kristen Robbins; Ann C Halbower
Journal:  J Pediatr       Date:  2013-12-07       Impact factor: 4.406

8.  Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role?

Authors:  Paschalis Steiropoulos; Nikolaos Papanas; Evangelia Nena; Maria Antoniadou; Evangelia Serasli; Sophia Papoti; Olga Hatzizisi; Georgios Kyriazis; Argyris Tzouvelekis; Efstratios Maltezos; Venetia Tsara; Demosthenes Bouros
Journal:  Mediators Inflamm       Date:  2010-06-08       Impact factor: 4.711

9.  The occurrence of sleep-disordered breathing among middle-aged adults.

Authors:  T Young; M Palta; J Dempsey; J Skatrud; S Weber; S Badr
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

Review 10.  The relationship of obesity and obstructive sleep apnea.

Authors:  Neomi Shah; Francoise Roux
Journal:  Clin Chest Med       Date:  2009-09       Impact factor: 2.878

View more
  15 in total

Review 1.  Obstructive Sleep Apnea and the Liver.

Authors:  Malav P Parikh; Niyati M Gupta; Arthur J McCullough
Journal:  Clin Liver Dis       Date:  2019-05       Impact factor: 6.126

2.  4-phenylbutyric acid attenuates endoplasmic reticulum stress-mediated apoptosis and protects the hepatocytes from intermittent hypoxia-induced injury.

Authors:  Liu Xin; Wu Fan; Du Tingting; Sun Zuoming; Zhang Qiang
Journal:  Sleep Breath       Date:  2018-10-15       Impact factor: 2.816

3.  Chronic Intermittent Hypoxia Increases Cell Proliferation in Hepatocellular Carcinoma.

Authors:  Lydie Carreres; Marion Mercey-Ressejac; Keerthi Kurma; Julien Ghelfi; Carole Fournier; Olivier Manches; Florent Chuffart; Sophie Rousseaux; Mélanie Minoves; Thomas Decaens; Herve Lerat; Zuzana Macek Jilkova
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

4.  Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Shanshan Jin; Suwen Jiang; Airong Hu
Journal:  Sleep Breath       Date:  2018-01-15       Impact factor: 2.816

Review 5.  Sleep apnea, metabolic disease, and the cutting edge of therapy.

Authors:  Matthew Light; Karen McCowen; Atul Malhotra; Omar A Mesarwi
Journal:  Metabolism       Date:  2017-09-28       Impact factor: 8.694

Review 6.  Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function.

Authors:  Thiago Thomaz Mafort; Rogério Rufino; Cláudia Henrique Costa; Agnaldo José Lopes
Journal:  Multidiscip Respir Med       Date:  2016-07-12

7.  Association between non-alcoholic fatty liver disease and obstructive sleep apnea.

Authors:  Ilaria Umbro; Valerio Fabiani; Mario Fabiani; Francesco Angelico; Maria Del Ben
Journal:  World J Gastroenterol       Date:  2020-05-28       Impact factor: 5.742

8.  Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease.

Authors:  Samshol Sukahri; Fatimah Zaherah Mohamed Shah; Ahmad Izuanuddin Ismail; Marymol Koshy; Bushra Johari; Mazuin Mohd Razali; Thuhairah Hasrah Abdul Rahman; Mohamad Rodi Isa; Rohana Abdul Ghani
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

9.  Clinical Manifestations and Diagnosis of Nonalcoholic Fatty Liver Disease.

Authors:  Mahmoodreza Khoonsari; Mohammadreza Mohammad Hosseini Azar; Ramak Ghavam; Khadijeh Hatami; Mosa Asobar; Ali Gholami; Abdolhalim Rajabi; Fahimeh Safarnezhad Tameshkel; Bahare Amirkalali; Masoudreza Sohrabi
Journal:  Iran J Pathol       Date:  2017-04-01

10.  Tauroursodeoxycholic acid attenuates endoplasmic reticulum stress and protects the liver from chronic intermittent hypoxia induced injury.

Authors:  Yanpeng Hou; Huai'an Yang; Zeshi Cui; Xuhui Tai; Yanling Chu; Xing Guo
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.